PMID: 8977597Oct 1, 1996Paper

Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants

Thorax
J H WildhaberP N LeSouëf

Abstract

A study was undertaken to determine the influences of electrostatic charge, flow, delay, and multiple actuations on the in vitro delivery of salbutamol generated by a pressurised metered dose inhaler (pMDI) from small volume spacers used in infants. Ten actuations from a salbutamol pMDI were drawn at different flow rates after either single or multiple actuations, with or without delay, through either static or reduced static spacers. An ionic detergent was used to reduce the charge of plastic spacers (Babyhaler, Babyspacer, Aerochamber, Nebuhaler). Electrostatic charge was measured using an electrometer. A multistage liquid impinger was used to determine the particle size distribution of the output of the pMDI through the spacers. Electrostatic charge on the surface of plastic spacers had the greatest influence on delivery, causing a decrease in drug delivery. Reducing charge by coating the surface with ionic detergent resulted in an increase of 46.5-71.1% (p < 0.001) in small (< 6.8 microns) particle delivery from small volume plastic spacers. Lower flow, delay, and multiple actuations resulted in decreased delivery from static spacers. Lower flow resulted in a decrease of 15% in small (< 9.6 microns) particle delivery. Delay...Continue Reading

References

May 1, 1992·Archives of Disease in Childhood·M L EverardA D Milner
Aug 1, 1991·The American Review of Respiratory Disease·R KraemerE Russi
Nov 1, 1985·The Journal of Pediatrics·H LevisonG H Worsley
Apr 1, 1988·The American Review of Respiratory Disease·I Gonda
Sep 1, 1995·Archives of Disease in Childhood·H BisgaardE Berg

❮ Previous
Next ❯

Citations

Mar 12, 2002·Pediatric Pulmonology·P N Le Souëf
Jul 6, 2000·Indian Journal of Pediatrics·R K Kumar
Sep 30, 2010·European Journal of Pediatrics·Jan Mazela, Richard A Polin
Jan 15, 2005·Pharmaceutical Research·Sylvia VerbanckWalter Vincken
Jul 5, 2003·Advanced Drug Delivery Reviews·P W Barry, C O'Callaghan
Jun 19, 2001·International Journal of Pharmaceutics·J C DubusM Dolovich
Sep 25, 2002·International Journal of Pharmaceutics·R JanssenP Zanen
Jul 25, 2003·International Journal of Pharmaceutics·J C DubusM Badier
May 25, 2007·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Daniel MenziesBrian Lipworth
Sep 6, 2000·British Journal of Clinical Pharmacology·J H WildhaberQ A Summers
May 21, 2003·Journal of Paediatrics and Child Health·J U BarbenC F Robertson
Oct 25, 2002·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·S G Devadason, P N Le Souef
May 4, 2004·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·J E Esposito-FestenH A W M Tiddens
Jan 1, 1997·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·J P Mitchell, M W Nagel
Jan 6, 2000·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·M TurpeinenA Pelkonen
Mar 21, 2000·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·W H Finlay, P Zuberbuhler
Oct 13, 2006·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Christina M RollerSunalene G Devadason
Mar 23, 2006·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Sunalene G Devadason
Apr 7, 2007·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·H M Janssens, H A W Tiddens
May 12, 2010·Journal of Aerosol Medicine and Pulmonary Drug Delivery·André SchultzSunalene G Devadason
Dec 18, 2004·Fundamental & Clinical Pharmacology·J C Dubus, M Dolovich
Jun 1, 2000·Archives of Disease in Childhood·H J ZarM D Mann
Jun 29, 2002·Archives of Disease in Childhood·S S GarnerD M Habib
Jun 24, 2003·Archives of Disease in Childhood·P M WattG M Chaney
Sep 6, 2003·Paediatric Drugs·Fernando Maria De Benedictis, David Selvaggio
Aug 8, 2013·Therapeutic Delivery·Jennifer WongPhilip Chi Lip Kwok
May 30, 2014·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Nicholas B CarrigyWarren H Finlay
Nov 15, 2013·Expert Review of Respiratory Medicine·Arzu Ari, James B Fink
Nov 22, 2005·Expert Opinion on Drug Delivery·Hugh D C Smyth
Apr 25, 2007·Journal of Pharmaceutical Sciences·Anthony J HickeyDimitris Papadopoulos
Jun 10, 2005·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·José Esposito-FestenHarm Tiddens
Mar 20, 2004·Pediatric Pulmonology. Supplement·Andrew Bush
Mar 20, 2004·Pediatric Pulmonology. Supplement·Harm Tiddens
Feb 15, 1997·Lancet·A Woodcock
Aug 29, 2013·ISRN Allergy·Federico Lavorini
Sep 7, 2016·Journal of Veterinary Pharmacology and Therapeutics·R S PirieG McLachlan
Dec 16, 2016·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Ariel BerlinskiKurt Nikander

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.